abstract |
The present invention relates to compounds of formula (I), or stereoisomers and pharmaceutically acceptable salts, as muscarinic M1 receptor positive allosteric modulators. The invention also relates to methods of preparing such compounds and pharmaceutical compositions comprising such compounds. The compounds of the invention are useful for the treatment of various disorders associated with muscarinic M1 receptors. |